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Homeostasis: A scavenger receptor for haemoglobin
Siamon Gordon
Recent studies have identified a macrophage-specific
receptor for the clearance of haemoglobin–haptoglobin
complexes, which protects the host against the toxicity
of free haemoglobin.
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Tissue macrophages are a major part of the mononuclear
phagocyte system and remove haemoglobin, generated by
intravascular haemolysis, in a complex with haptoglobin, a
plasma protein produced by the liver [1]. A recent study
has shown that the CD163 receptor — a differentiation
antigen restricted to tissue macrophages — binds and
internalises the haptoglobin–haemoglobin complex, but
not free haemoglobin nor haptoglobin [2]. CD163 contains
multiple tandem repeats of the scavenger receptor cys-
teine-rich (SRCR) domain [3], a motif commonly found in
proteins involved in endocytosis and cellular adhesion [4].
The CD163 receptor may therefore be central to the
homeostatic functions of tissue macrophages to prevent
haemoglobin toxicity, and may also have a role in recy-
cling iron [2].
Senescent or malformed red blood cells are cleared by
tissue macrophages mainly in spleen, liver and bone
marrow, by still poorly defined receptors [5]. The safe
catabolism of haemoglobin, formation of bile pigment and
recycling of iron thus take place outside the circulation.
Intravascular haemolysis generates haemoglobin which is
stoichiometrically complexed to haptoglobin for clearance
by tissue macrophages. However, if the buffering capacity
of plasma haptoglobin is exceeded, for example through
the pathological destruction of erythrocytes, then free
haemoglobin can be filtered by the kidney, reabsorbed by
the renal tubular epithelium, or excreted in urine — as
occurs in blackwater fever during episodes of malaria.
Lower affinity complexes of haem compounds can also
form with haemopexin and albumin [6].
Haptoglobin is produced as an acute phase plasma protein
by hepatocytes during the early response to host injury.
The protein is synthesised as a single chain, which is
cleaved to an amino-terminal α-chain and a carboxy-ter-
minal β-chain [7]. The development of non-denaturing
starch gel electrophoresis by Oliver Smithies led to the
discovery of a human polymorphism of two alleles that is
common to all populations. Variant proteins differ in the
length of their α-chains — designated α1 and α2 — and
the ready identification of homozygous Hp(1-1) and
Hp(2-2), and heterozygous Hp(2-1) human phenotypes
has resulted in putative disease associations, but the
selective advantage, if any, of either allele remains
unclear [8].
Figure 1
Schematic representation of scavenger receptor A isoforms and
CD163 (adapted from [21]). Note the trimeric nature of SRA I and
SRA II. Cysteine-rich domain (orange); scavenger receptor cysteine-
rich domain (Sc, green); glycosylation site (black).
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The strategy followed by Kristiansen and colleagues [2] to
identify the putative haemoglobin scavenger receptor was
simple and effective. Haemoglobin–haptoglobin (Hb–Hp)
complexes were used directly to isolate a single protein
from spleen, placenta and liver lysates. Subsequent microse-
quencing and database searches identified the protein as a
known member of the SRCR family, CD163 (Figure 1).
This molecule had already been identified as a differentia-
tion antigen [3] and various monoclonal antibodies had
been generated against the human protein.
CD163 is expressed at high levels by mature tissue
macrophages — which are abundant in spleen, placenta
and liver — and at lower levels by monocytes freshly iso-
lated from blood [9]. Ligand blots confirmed that CD163
only bound Hb–Hp complexes, not free haemoglobin nor
haptoglobin [2], implying that a new epitope was exposed
by the complex. The CD163 receptor contains a hydropho-
bic internalisation motif in its cytoplasmic tail. Cells trans-
fected with CD163 cDNA were able to endocytose Hb–Hp
complexes showing that CD163 is an effective endocytic
receptor. Binding assays showed that CD163 had a greater
affinity for Hb–Hp(2-2) complexes than for Hb–Hp(1-1)
complexes [2]. In addition, the uptake of complexed
haemoglobin by CD163 was followed by degradation of
the cargo, supporting a role for CD163 as a scavenger recep-
tor that removes intravascular haemoglobin [2].
The expression of CD163 is increased by interleukin-10,
an anti-inflammatory immunomodulator, as well as by glu-
cocorticoids. And both CD163 and haptoglobin are greatly
upregulated by interleukin-6, a proinflammatory, acute
phase-inducing cytokine [9,10]. The coordinate induction
of receptor and ligand by these factors is possibly a
mechanism to enhance the capacity for haemoglobin
clearance in response to injury. Antibody-mediated cross-
linking of CD163 has been reported to induce intracellular
signalling, including interleukin-6 expression, and CD163
may also be shed from the cell surface, presumably by pro-
teolysis. The possible functional significance for clearance
of Hb–Hp remains to be discovered. In addition, isoforms
of the CD163 molecule have been identified which differ
in their cytoplasmic tails although as yet, no functional dif-
ferences have been described [3]. Finally, gp160 is a
closely linked gene whose product may cross-react with
different anti-CD163 monoclonal antibodies and which
could have similar functions in vivo [11]. 
The term scavenger receptor has become rather loosely
used to denote a variety of endocytic receptors. The proto-
typical scavenger receptor, SR-A, was discovered to be a
tissue macrophage receptor for the endocytosis of modi-
fied, but not native low density lipoproteins [12] (reviewed
in [13]). The receptor has two major isoforms: SR-A I has a
carboxy-terminal, extracellular cysteine-rich domain that is
absent in SR-A II (Figure 1). Ironically, the binding site
for a range of polyanionic ligands is thought to be in the
collagenous region, rather than in the cysteine-rich domain
itself; no functional difference has so far been shown for
the different isoforms. SR-B receptors are structurally
unrelated to SR-A receptors and lack SRCR domains [13].
Scavenger receptors have been implicated in endocytosis,
phagocytosis of apoptotic cells and cell adhesion, and are
thought to contribute to host defence as well as lipoprotein
homeostasis and atherogenesis [14].
Somewhat confusingly, SRCR domains have been classi-
fied as type A, with two exons per domain, as in SR-A, or
Table 1
Properties of selected SRCR-domain containing receptors.
Type No. domains/chain Receptor Ligand Comment References
A Domains 1 SR-AI Modified lp, AGE, poly I, LPS, LTA MØ, endocytosis, phagocytosis 12
(2 exons/domain) (selected polyanions) apoptotic cells and bacteria,
adhesion
1 MARCO Modified lp, bacteria SR-A like, longer collagenous domain, 13
Restricted MØ expression
1 Mac 2 binding protein Galectin-3 (Mac 2) X-ray structure elucidated 14
(cyclophilin C)
B Domains 9 CD163 Hp–Hb complexes MØ, endocytosis 2
(1 exon/domain) 3 CD6 CD166 (ALCAM), (IgSF member) Leukocyte interactions 15
3 Spa (AIM) Selected myeloid & lymphoid cells Apoptosis inhibitor secreted by MØ 16
13 Gp 340 ?Surfactant protein D MØ & selected epithelia 17
Abbreviations: lp, lipoprotein; poly I, polyinosinic acid; AGE,
advanced glycation endproducts; LPS, lipopolysaccharide; LTA,
lipoteichoic acid; IgSF, immunoglobulin superfamily; MØ, tissue
macrophage.
as type B domains which are encoded by a single exon, as
found in CD163. The SRCR domain is not restricted to
the scavenger receptors but is also found in cell-surface
proteins on macrophages, lymphocytes and exocrine cells
(see Table 1) and may be evolutionarily ancient, as shown
in a recent study of sea urchins [15]. The identification of
CD163 as a scavenger receptor for Hb–Hp complexes is a
major advance in identifying physiological ligands and
functions for this type of domain — the CD163 protein
contains little else in its extracellular part, though it remains
to be shown which domains are responsible for Hb–Hp
complex binding. There is a precedent for a different type
of cysteine-rich domain which is found in the tissue
macrophage mannose receptor. This domain confers upon
the mannose receptor a specialised endocytic function that
allows the uptake of sulphated glycoconjugates and is dis-
tinct from its classical C-type lectin activity [16].
Macrophages display a wide range of plasma membrane
receptors to recognise potentially injurious changes within
the host, as well as exogenous ligands. Their responses to
receptor ligation include suppression of inappropriate
inflammatory and immunological reactions as well as the
generation of powerful cytocidal and anti-microbial media-
tors. The potential for haem-containing complexes, and
iron in complex forms, to interact with, and potentiate
macrophage-derived reactive oxygen metabolites is con-
siderable, and may contribute to tissue injury and patho-
logical processes such as atherosclerosis. Uncovering the
clearance mechanisms linking tissue macrophages, hapto-
globin and free haemoglobin will stimulate interest in the
underlying genetic susceptibility to, and pathogenesis of,
common and major diseases [8].
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